Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-22 · accession 0001493152-25-029355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-22 | INDP | Meckler Jeffrey A | Co-CEO, Dir, 10% | A - Grant | $2.03 | +216.6K | 229.9K | +1,627% | +$439.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | A | A | 216,617 | $2.03 | 229,929 | D | — | — | (F1) The Reporting Person acquired 216,617 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025. |